Ads by Google

PHOTO: Oct. 18: Diversified Global Holdings Winning Partnership With Nike And Team KIN

On Oct. 9, 2009, Diversified Global Holdings located in Orlando, Fla., contributed to the Nike Women's Marathon by sponsoring the KIN running team in an effort to support Leukemia research. The Nike Women's Marathon will take place on October 18, 2009. The race will benefit the Leukemia & Lymphoma Society (LLS) of San Francisco, Calif.

Nike's year-round marathon training program reaches highly-motivated and dedicated women and men who are active consumers and interested in taking on the ultimate challenge of running or walking a marathon, completing a 100-mile century ride or a triathlon.

"Diversified Global Holdings and Nike's contributions support the Leukemia & Lymphoma Society's lifesaving cancer research," said Diversified Global Holdings Chairman Vadim Enikeev. "We're proud to be helping improve the lives of thousands of Americans battling blood cancers.

Jackie Steinhart from team KIN thanked Diversified Global Holdings CEO Richard Lloyd personally saying, "The knowledge that Diversified Global Holdings shares our commitment to this important cause will keep us going, and you will be in our minds and hearts as we cross the finish line!"

"The devastation of Leukemia has touched my family personally, and I can only hope to continue to do all I can to support such a worthy cause," said CEO Richard Lloyd. "We look forward to working with Nike, team KIN and the LLS again in the future."

The Leukemia & Lymphoma Society is the world's largest voluntary health organization dedicated to funding blood cancer research and providing education and patient services. Over more than $680 million in research has been funded, with over $69 million in 2009, specifically targeting leukemia, lymphoma and myeloma. Last year alone, LLS made 4.9 million contacts with patients, caregivers and healthcare professionals.

To help contribute to this foundation, visit http://mch.nikewm.llsevent.org/pledge/index.cfm?mid=TEAMKIN4LLS

For more information about Diversified Global Holdings or Team Kin, contact:

Sydney Lynn

5612513403

umbrella.flpr@gmail.com

HTML: http://www.eworldwire.com/pressreleases/211289

PDF: http://www.eworldwire.com/pdf/211289.pdf

ONLINE NEWSROOM: http://www.eworldwire.com/newsroom/314909

RSS NEWSROOM: http://newsroom.eworldwire.com/xml/newsrooms/314909.xml

Source: Diversified Global Holdings

Sydney Lynn
Umbrella PR
12609 Weatherford Way
Orlando, FL 32832
PHONE. 561-251-3403
EMAIL: sydclynn@gmail.com

Copyright (C) 2009 EWorldWire. All rights reserved

News Provided by COMTEX


Related terms: cancer, ceo, contributions, education, family, foundation, health, healthcare, html, men, online, partnership, research, sydney, training, women

Related Articles

Royal Style Design Signs Letter Of Intent With Diversified Global Holdings - Zibb.com
Oct 30, 2009
...Design Signs Letter Of Intent With Diversified Global Holdings Royal Style Design Inc. (OTCBB...has signed a Letter of Intent with Diversified Global Holdings. Diversified Global Holdings is an international company with eight...

Taco Bell Franchisee Raises Funds for Leukemia & Lymphoma Society
Oct 27, 2009
...Franchisee Raises Funds for Leukemia & Lymphoma Society Austaco Ltd., a franchisee...million dollars for The Leukemia & Lymphoma Society of Central Texas (LLS). ...million dollars for The Leukemia & Lymphoma Society of Central Texas (LLS). As...

CoActiv Capital Partners, Inc.: CoActiv Capital Partners, Inc. Supports The Leukemia & Lymphoma Society Through Participation and Giving in the Annual Light The Night(R) Walk
Nov 3, 2009
...Inc. Supports The Leukemia & Lymphoma Society Through Participation and Giving...over $10,000 for The Leukemia & Lymphoma Society's annual Light The Night Walk. The Leukemia & Lymphoma Society holds Walks each fall in approximately...

Freeport not boosting U.S. copper output
Oct 26, 2009
...Arizona) is going to be contingent on our seeing clear evidence of recovery of copper demand in the U.S. and Europe," CEO Richard Adkerson tells analysts in a conference call. "And we haven't seen that yet." He says the same could be said of molybdenum...